Jason Ruth

Company: Wellington Management Company, LLP

Job title: Biotech Private Investments Sector Lead

Bio:

Jason is an investor with the Private Investments team focusing on mid- to late-stage private biotech companies developing clinically impactful new medicines. He is responsible for sourcing investment opportunities, leading due diligence, evaluating and negotiating deal terms, and managing the investments until their exit.
Prior to joining Wellington Management in 2024, Jason was a Partner with MRL Ventures, the corporate venture capital arm of Merck (2022 – 2024). Jason began his investing career at 5AM Ventures (2017 – 2022) where he started in early-stage biotech venture capital and venture creation, and from 2020 – 2022 helped establish the firm’s public investment activities. Before this, he conducted cancer research at the Broad Institute with Levi Garraway from 2014 – 2016.

Seminars:

Investor Icebreaker: When Being Selective, where will Investors Invest? 11:45 am

For both venture and investing out of public funds, what will drive investment in ADCs and what will inhibit it?  With the data readouts from ASCO, will your considerations for investment change?  How can and will ADCs remain relevant to investors?Read more

day: Day One P2